Accelerated iTBS for Post Partum Depression

Description

Study 1: The investigators are studying the feasibility and tolerability of 10x/day intermittent theta burst (excitatory) transcranial magnetic stimulation to the left dorsolateral prefrontal cortex over the course of 6 days for women with post-partum depression. The investigators further aim to characterize the anticipated anti-depressant effect of this treatment paradigm. Study 2: The investigators are studying the feasibility and tolerability of 12 sessions/day of intermittent theta burse (excitatory) transcranial magnetic stimulation to the left dorsolateral prefrontal cortex over 5 days for women with post-partum depression. The investigators aim to compare the two different treatment schedules.

Conditions

Post Partum Depression

Talk to us

Study Overview

On this page

Study Details

Study overview

Study 1: The investigators are studying the feasibility and tolerability of 10x/day intermittent theta burst (excitatory) transcranial magnetic stimulation to the left dorsolateral prefrontal cortex over the course of 6 days for women with post-partum depression. The investigators further aim to characterize the anticipated anti-depressant effect of this treatment paradigm. Study 2: The investigators are studying the feasibility and tolerability of 12 sessions/day of intermittent theta burse (excitatory) transcranial magnetic stimulation to the left dorsolateral prefrontal cortex over 5 days for women with post-partum depression. The investigators aim to compare the two different treatment schedules.

An Open Label Study to Assess the Feasibility and Tolerability of Accelerated Theta Burst Repetitive Transcranial Magnetic Stimulation (iTBS-rTMS) for the Treatment of Post-Partum Depression

Accelerated iTBS for Post Partum Depression

Condition
Post Partum Depression
Intervention / Treatment

-

Contacts and Locations

Charleston

Medical University of South Carolina, Charleston, South Carolina, United States, 29425

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Participants must be able to provide informed consent and function at an intellectual level sufficient to allow accurate completion of all assessment instruments.
  • 2. Participants must be over the age of 18.
  • 3. Participants must meet criteria for post-partum depression: a) onset of symptoms in the first year postpartum
  • 4. Participants must have a HRSD17 greater than or equal to 14 at baseline.
  • 1. Participants must not be pregnant.
  • 2. Participants must not meet moderate or severe use disorder of any substance with the exception of Tobacco Use Disorder.
  • 3. Participants must not have current psychotic symptoms.
  • 4. Participants must not have a history of dementia or other cognitive impairment.
  • 5. Participants must not have active suicidal ideation requiring hospitalization or a suicide attempt within the past 3 months.
  • 6. Participants must not have any contraindications to receiving rTMS (e.g. metal implanted above the neck, history of seizure, any known brain lesion).
  • 7. Participants must not have any unstable general medical conditions.
  • 8. Participants must not have had eclampsia during pregnancy.

Ages Eligible for Study

18 Years to 50 Years

Sexes Eligible for Study

FEMALE

Accepts Healthy Volunteers

No

Collaborators and Investigators

Medical University of South Carolina,

Study Record Dates

2024-12